Drug intelligence / Profile preview

2,3-dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinolin-6-ium

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** \n2,3-dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinolin-6-ium is an experimental small molecule belonging to the isoquinoline and derivatives class of organic compounds. It is a polycyclic aromatic compound with the molecular formula C19H16NO4 and a monoisotopic mass of approximately 322.11 g/mol. The compound has been studied as part of a broader class of indenoisoquinolines for their potential anticancer properties due to their ability to inhibit DNA topoisomerase I—a key enzyme involved in DNA replication and transcription.\n\nIndenoisoquinolines (including closely related analogs) have demonstrated strong cytotoxicity in cancer cell lines by stabilizing the covalent complex between topoisomerase I and DNA (the "cleavable complex"), thereby preventing religation of single-strand breaks during DNA replication and leading to cell death in rapidly dividing cells.

Other names
2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM15,16-dimethoxy-5,7-dioxa-20-azapentacyclo[10.8.0.0^{2,10}.0^{4,8}.0^{13,18}]icosa-1(12),2(10),3,8,13,15,17,19-octaen-20-ium2,3-Dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinolin-6-ion
02

Targets

TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on 2,3-dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinolin-6-ium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,3-dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-c]isoquinolin-6-ium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call